VANGUARD GROUP INC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$398,896
-18.1%
1,015,0040.0%0.00%
Q4 2022$487,202
-71.1%
1,015,004
+0.5%
0.00%
Q3 2022$1,686,000
-41.2%
1,010,1340.0%0.00%
Q2 2022$2,868,000
-28.2%
1,010,134
+27.2%
0.00%
Q1 2022$3,994,000
-49.7%
794,299
-0.3%
0.00%
Q4 2021$7,946,000
+245.3%
796,948
+350.4%
0.00%
Q3 2021$2,301,000
-6.4%
176,929
+1.2%
0.00%
Q2 2021$2,459,000
+335.2%
174,795
+399.4%
0.00%
Q1 2021$565,00035,0000.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders